Our results showed a significant decrease in Muc2 mRNA in obese colitis mice, an effect reversed in mice administered with IAP, suggesting, on the one hand, a possible reduction in mucus production capacity in obesity and, on the other hand, supporting the idea that IAP contributes to the restoration of mucus formation. This evidence concerns the gene MUC2 and colitis.